Literature DB >> 4775737

Factors influencing the survival of patients with transitional cell tumours of the urinary bladder.

J P Pryor.   

Abstract

Entities:  

Mesh：

Year:  1973        PMID： 4775737     DOI： 10.1111/j.1464-410x.1973.tb12227.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN： 0007-1331


× No keyword cloud information.
  10 in total

1.  D-type cyclins in superficial and muscle-invasive bladder urothelial carcinoma: correlation with clinicopathological data and prognostic significance.

Authors:  Georgia Levidou; Angelica A Saetta; Maria Karlou; Irene Thymara; Harris Pratsinis; Petros Pavlopoulos; Dimitrios Isaiadis; Kalliopi Diamantopoulou; Efstratios Patsouris; Penelope Korkolopoulou
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-20       Impact factor: 4.553

2.  ACP Broadsheet 130: November 1991. Gross examination of bladder specimens.

Authors:  M C Parkinson; C Fisher
Journal:  J Clin Pathol       Date:  1991-11       Impact factor: 3.411

Review 3.  Epidermal growth factor receptor and bladder cancer.

Authors:  A J Colquhoun; J K Mellon
Journal:  Postgrad Med J       Date:  2002-10       Impact factor: 2.401

4.  Bladder cancer.

Authors:  O J Traynor; A E Carter
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-27

5.  The value of tumour spread, grading and growth pattern as morphological predictive parameters in bladder carcinoma. A critical revision of the 1987 TNM classification.

Authors:  J C Angulo; J I Lopez; N Flores; J D Toledo
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 6.  Chemotherapy in the management of invasive bladder cancer. A review.

Authors:  H Bush; N Thatcher; R Barnard
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

7.  Clinical significance of nuclear factor (NF)-kappaB levels in urothelial carcinoma of the urinary bladder.

Authors:  Georgia Levidou; Angelica A Saetta; Penelope Korkolopoulou; Polyanthi Papanastasiou; Katerina Gioti; Petros Pavlopoulos; Kalliopi Diamantopoulou; Eupthemia Thomas-Tsagli; Konstantinos Xiromeritis; Efstratios Patsouris
Journal:  Virchows Arch       Date:  2008-03       Impact factor: 4.064

8.  Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder.

Authors:  L M Coombs; D A Pigott; E Sweeney; A J Proctor; M E Eydmann; C Parkinson; M A Knowles
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

9.  Prognostic factors in a T3 bladder cancer trial. Co-operative Urological Cancer Group.

Authors:  A Babiker; R J Shearer; C E Chilvers
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

10.  Reduced expression of TGF beta is associated with advanced disease in transitional cell carcinoma.

Authors:  L M Coombs; D A Pigott; M E Eydmann; A J Proctor; M A Knowles
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.